medigraphic.com
Colegio de Medicos y Cirujanos República de Costa Rica

2008, Number 582

<< Back Next >>

Rev Med Cos Cen 2008; 65 (582)

Esclerosis Multiple

Loría MM

Language: Spanish
References: 14
Page: 27-30
PDF size: 383.96 Kb.


ABSTRACT

An unpredictable disease of the central nervous system, multiple sclerosis (MS) can range from relatively benign to somewhat disabling to devastating, as communication between the brain and other parts of the body is disrupted. Many investigators believe MS to be an autoimmune disease. In the case of MS, it is the nerve insulating myelin that comes under assault. Most people experience their first symptoms of MS between the ages of 20 and 40. Most MS patients experience muscle weakness in their extremities and difficulty with coordination and balance. These symptoms may be severe enough to impair walking or even standing. In the worst cases, MS can produce partial or complete paralysis. Most people with MS also exhihit paresthesias, transitory abnormal sensory feelings such as numbness, prickling, or “pins and needles” sensations. Some may also experience pain. Occasionally, people with MS have hearing loss. Approximately half of ah people with MS experience cognitive impairments.


REFERENCES

  1. Desola J. Oxigenoterapia hiperbárica en el tratamiento de la esclerosis múltiple. Med Clin (Barc) 1984;83(13):562.

  2. Desola J. Utilización de oxigenoterapia hiperbárica en el tratamiento de la esclerosis múltiple. En: Matías-Guiu J, Bigorra J, ed. Perspectivas terapéuticas en la esclerosis múltiple. Fundación Dr. Esteve, Barcelona, 1989;47-56.

  3. D.C.Hooper et al. “Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: Implications for the treatment of multiple sclerosis” Proc. natl. Acad. Sci. USA; Vol 94, pp.2528-2533, March 1997, Medical Sciences.

  4. D.C.Hooper et al. “local nitric oxide production in viral and autoinmune diseases of the central nervous system” Proc. natl. Acad. Sci. USA; Vol 92, pp.5312-5316, June 1995, Medical Sciences.

  5. García Albea E. Síntomas agudos psiquiátricos y esclerosis múltiple. Rev. Clin. Esp. 1987; 181: 168-169.

  6. Harrison. Principios de Medicina Interna. 1994. 13a Edición. Vol I 1309-1310.

  7. Herrero JS, Muñoz D, Escriche D, Pérez, Haza MA, Gómez AlonsoJ. Psicosis y esclerosis múltiple. Neurología 1990; 10: 407.

  8. Hollender MH, Steckler PP. Multiple sclerosis and schizophrenia: a case report. Psychiatr. Med. 1972; 3: 251-257.

  9. Hooper et al. “Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalomyelitis and multiple sclerosis” Proc. natl. Acad. Sci.USA; Vol 95, pp.675-680, January 1998, Medical Sciences.

  10. Kolher J, Heilmeyer H, Volk B. Multiple sclerosis presenting as chronic atypical psychosis. J. Neurol. Neurosurg. Psychiatry 1988; 51: 281-284.

  11. Mattews WB. Multiple sclerosis presenting with acute remitting psychiatric symptoms. J. Neurol. Neurosurg. Psychiatry 1979; 42:859-863.

  12. Surridge D. An investigation into some psychiatric aspects of multiple sclerosis. Br. J. Psychiat. 1969; 115: 749-764.

  13. Pratt RTC. An investigation of the psychiatric aspects of disseminated sclerosis. J. Neurol. Neurosurg. Psychiatry 1951; 14: 326-335.

  14. Templer Di, Cappallety GG, Kaufman I. Schizophrenia and multiple sclerosis. Distribution in Italy. Br. J. Psychiat.; 1988, 153: 389-390.




2020     |     www.medigraphic.com